The dramatic gross margin swings, including a negative margin in 2024Q4, suggest that Amarin's product economics are highly unstable, likely due to pricing pressure and inventory write-downs. Operating margins have been consistently negative, with the latest quarter at -28.5%, implying that SG&A and R&D costs far exceed gross profit. This pattern indicates that the company's cost structure is not aligned with its revenue base, and profitability is unlikely to recover without significant restructuring or revenue stabilization.

The cash conversion cycle has remained elevated above 600 days for most of the past year, with inventory days spiking to 581 in 2026Q2. This suggests that Amarin is holding excessive inventory relative to its sales, possibly due to declining demand or supply chain issues. The high DSO of 217 days indicates slow collection from customers, which may strain liquidity despite the low debt levels. These working capital inefficiencies are likely contributing to the erratic cash flow patterns observed, as cash is tied up in non-productive assets.

While the current ratio appears healthy, the absolute cash decline is concerning given the ongoing operating losses. The quick ratio of 2.67 suggests that inventory is not a major liquidity concern, but the persistent cash burn from operations, despite occasional positive quarters, may erode this buffer. Investors should monitor whether the company can sustain its liquidity position without additional financing or drastic cost reductions, as the current ratio may overstate financial flexibility.

Amarin's balance sheet shows minimal debt, which provides a cushion against insolvency, but the lack of leverage may reflect constrained borrowing capacity given the company's losses. Interest coverage is not meaningful due to the low debt, but the company's negative equity returns and persistent losses suggest that it cannot service additional debt without further diluting shareholders. The low D/E ratio may indicate that the company is relying on equity financing, which could be costly given the depressed stock price.

The negative ROIC, despite a low asset base, suggests that Amarin is not generating sufficient returns on its invested capital, and the shrinking asset base reflects a contracting business. The decline in equity from $545.9M to $443.6M over the same period, driven by retained losses, indicates that the company is eroding shareholder value. The lack of positive returns, combined with the asset-light model, implies that the company's capital is not being deployed effectively, and investors should question the viability of the current strategy.